Kawasaki, Japan

Yoichiro Shima

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2008-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoichiro Shima. Retrieved from https://idiyas.com/inventor/yoichiro-shima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 


Average Co-Inventor Count = 11.7

ph-index = 4

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yoichiro Shima

Introduction

Yoichiro Shima is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work focuses on developing compounds that address critical health issues.

Latest Patents

Among his latest patents are the Pyrazolo-pyrimidine compounds, which are designed to inhibit IL-12/IL-23 production. This invention provides a pharmaceutical composition aimed at preventing or treating diseases related to excess production of IL-12/IL-23. Another notable patent involves specific phenylalanine derivatives, which exhibit antagonistic activity to α4 integrin. These derivatives are utilized as therapeutic agents for various diseases associated with α4 integrin.

Career Highlights

Yoichiro Shima is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His innovative work has contributed to advancements in therapeutic solutions, showcasing his expertise and dedication to improving health outcomes.

Collaborations

He has collaborated with notable coworkers, including Tadakiyo Nakagawa and Tamotsu Suzuki, further enhancing the impact of his research and inventions.

Conclusion

Yoichiro Shima's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing significant health challenges. His work continues to influence the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…